NUVL 75.84 (-0.2%)
US6707031075BiotechnologyBiotechnology

Nuvalent (NUVL) Stock Highlights

75.84 | -0.2%
2025-01-20 02:00:59
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.

Statistics

Range Today
74.34 77.23
Volume Today 504.5K
Range 1 Year
61.79 113.51
Volume 1 Year 113.12M
Range 3 Year
7.09 113.51
Volume 3 Year 273.35M
Range 10 Year
7.09 113.51
Volume 10 Year 292.07M

Highlights

Market Capitalization 5.4B (mid)
Floating Shares 41M
Current Price 75.84
Price To Earnings -22.12
Price To Book 4.8
Earnings Per Share -3.48
Payout Ratio 0%

Performance

Latest -0.2%
1 Month -12.32%
3 Months -27.86%
6 Months -7.94%
1 Year +4%
3 Years +515.09%
5 Years +319.01%
10 Years +319.01%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.